tiprankstipranks
Oncotelic Therapeutics (OTLC)
OTHER OTC:OTLC
US Market
OTLC
Oncotelic Therapeutics
RESEARCH TOOLSreports
Want to see OTLC full AI Analyst Report?

Oncotelic Therapeutics (OTLC) Income Statement

86 Followers

Oncotelic Therapeutics Income Statement

Last quarter (Q4 2025), Oncotelic Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Oncotelic Therapeutics's net income was $250.35M. See Oncotelic Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Dec 23Mar 23Mar 22
Total Revenue
$ 0.00$ 0.00$ 70.00K$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 70.00K$ -12.84K$ -61.51K
Operating Expenses
$ 3.19M$ 376.01K$ 6.72M$ 5.61M$ 9.13M
Depreciation and Amortization
$ 0.00$ 376.01K$ 12.84K$ 12.84K$ 61.51K
EBITDA
$ -3.19M$ -3.55M$ -7.16M$ -5.60M$ -9.06M
Operating Income
$ -3.19M$ -3.58B$ -6.65M$ -9.72M$ -9.13M
Other Income/Expenses
$ 363.76M$ -947.92M$ -1.56M$ 14.40M$ -1.39M
Pretax Income
$ 360.57M$ -4.52B$ -8.21M$ 4.68M$ -10.52M
Net Income
$ 249.28M$ -4.52B$ -7.90M$ 17.82M$ -11.39M
Per Share Metrics
Basic EPS
$ 0.59$ -0.01$ -0.02$ 0.05$ -0.04
Diluted EPS
$ 0.59$ -0.01$ -0.02$ 0.04$ -0.04
Weighted Average Shares Outstanding
 421.05M 404.40M 396.17M 384.08M 303.08M
Weighted Average Shares Outstanding (Diluted)
 421.05M 404.40M 396.17M 457.30M 303.08M
Currency in USD

Oncotelic Therapeutics Earnings and Revenue History